Ishizuka Mitsuru, Nagata Hitoshi, Takagi Kazutoshi, Kubota Keiichi
Department of Gastroenterological Surgery, Dokkyo Medical University, Tochigi, Japan.
J Surg Oncol. 2008 Jul 1;98(1):67-9. doi: 10.1002/jso.21064.
The Groshong catheter (GC) is commonly used as a peripherally inserted central catheter (PICC), and the external jugular vein (EJV) is not a common route for central venous access (CVA). Therefore, external jugular venous catheterization (EJVC) using a GC is rare. However, our experience has shown that this procedure is safe and simple for CVA.
To assess the utility of EJVC using the GC for CVA.
CVA was done using a GC via the EJV with a single puncture employing the maximal barrier precaution technique.
Between March 2005 and June 2007, we attempted to perform EJVC using a GC via the EJV for 331 patients. Among of these patients, 301 patients received successful catheterization (success rate: 301/331 = 90.9%). The total period of catheter insertion was 4601 days, and the mean insertion period was 15.1 days (range 2-147 days). The main complications of catheter insertion were malposition (8/301; 2.7%) and, oozing or hematoma formation (8/301; 2.7%). There were no severe complications such as nerve injury, pneumothorax or arterial bleeding.
Our experience demonstrates that EJVC using the GC is acceptable for CVA.
Groshong导管(GC)常用于外周静脉穿刺中心静脉置管(PICC),而颈外静脉(EJV)并非中心静脉通路(CVA)的常用途径。因此,使用GC进行颈外静脉置管(EJVC)的情况较为罕见。然而,我们的经验表明,该操作对于CVA而言安全且简便。
评估使用GC进行EJVC用于CVA的实用性。
采用最大屏障预防技术,经EJV单次穿刺使用GC进行CVA。
在2005年3月至2007年6月期间,我们尝试对331例患者经EJV使用GC进行EJVC。在这些患者中,301例患者置管成功(成功率:301/331 = 90.9%)。导管插入总时长为4601天,平均插入时长为15.1天(范围2 - 147天)。导管插入的主要并发症为位置不当(8/301;2.7%)以及渗血或血肿形成(8/301;2.7%)。未出现诸如神经损伤、气胸或动脉出血等严重并发症。
我们的经验表明,使用GC进行EJVC可用于CVA。